Suchergebnisse - "Mikesch, Jan-Henrik"

PubPharm (134)

31

A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy

enthalten in: Annals of hematology | 2022

von Berdel, A. | Koch, R. | Gerss, J. | +15

32

Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies : Experiences in a Real-World Scenario

enthalten in: Cancers | 2022

von Krekeler, C. | Reitnauer, L. | Bacher, U. | +17

33

Intensified cytarabine dose during consolidation in AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

enthalten in: ResearchSquare.com | 2022

von Hanoun, M. | Ruhnke, L. | Kramer, M. | +30

34

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

enthalten in: Journal of cancer research and clinical oncology | 2022

von Hanoun, M. | Ruhnke, L. | Kramer, M. | +30

35

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

enthalten in: Journal of cancer research and clinical oncology | 2022

von Hanoun, M. | Ruhnke, L. | Kramer, M. | +30

36

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

enthalten in: Journal of cancer research and clinical oncology | 2022

von Hanoun, M. | Ruhnke, L. | Kramer, M. | +30

37

Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers : A Retrospective Analysis

enthalten in: Cancers | 2022

von Shumilov, E. | Aperdannier, L. | Schmidt, N. | +20

38

Adrenomedullin-CALCRL Axis Controls Relapse-Initiating Drug Tolerant Acute Myeloid Leukemia Cells

enthalten in: ResearchSquare.com | 2022

von Larrue, C. | Guiraud, N. | Dubois, M. | +22

39

Emerging antibody-based therapies for the treatment of acute myeloid leukemia

enthalten in: Cancer treatment reviews | 2022

von Angenendt, L. | Mikesch, J. | Schliemann, C.

40

Using stroma-anchoring cytokines to augment ADCC : a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse

enthalten in: Blood advances | 2022

von Berdel, A. | Ruhnke, L. | Angenendt, L. | +21